HR 4116
115th Congress
House
Health
Accounting and auditing
Business records
Congressional oversight
Corporate finance and management
Government studies and investigations
Health care costs and insurance
Inflation and prices
Intellectual property
Marketing and advertising
Medical research
Prescription drugs
Product development and innovation
Research administration and funding
Research and development
Small business
Wages and earnings
Transparent Drug Pricing Act of 2017
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 27, 2017
Referred to the Subcommittee on Health.
Oct 25, 2017
Referred to the House Committee on Energy and Commerce.
Oct 25, 2017
Introduced in House
Plain-English summary
Transparent Drug Pricing Act of 2017
This bill requires drug manufacturers to report specified financial and sales information, including drug pricing, tax credit, and patent information; violations are subject to civil penalties.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2